This month we are conducting a research study to screen all pregnant women at The Ottawa Hospital for Coronavirus (COVID-19), to test for the virus and immunity against the virus. By conducting this study, we hope to better understand the burden of active COVID-19 infection among pregnant women in our community. We will also explore the impact of COVID-19 infection on newborn immunity by using existing samples collected as part of Newborn Screening Ontario.
If you are presenting to an obstetrical triage unit at The Ottawa Hospital (General or Civic campuses), you are eligible to participate in this study. Participation will occur at the campus you are currently attending for your obstetrical care. Taking part in this study is voluntary, and if you do not want to provide all of the samples (listed below), it will not affect your current or future health care.
If you are interested in participating in the study, please let the nurse attending for your care know. They will inform you on next steps. If you choose to participate you can choose to provide one or more of the following sample types:
You can choose to provide one or more of the following sample types:
There are no medical risks to study participation. Some people find the sample collection (the swab or blood draw) to be uncomfortable. You may learn more about your COVID-19 infection and immune response during the study.
You will only need to provide samples one time (at your current visit), unless you return to the triage unit and are suspected with COVID-19. At that time, we will ask you for the nasopharyngeal swab and blood sample from you again, but you will have the opportunity to consent or decline. The newborn screening sample will be collected shortly after birth, as part of standard of care. After routine testing, if you provide consent, the additional COVID-19 testing will be done on your newborn’s sample
If you choose to participate in the study, you can access the test results of your research samples through MyChart. The results from the samples we collect from you will appear within 2 weeks after collection. The tests performed are for research purposes only. If at any point you develop COVID-19 symptoms, please follow Ottawa Public Health guidelines (e.g. self-isolate and get tested) and consult your healthcare provider.
The results from your newborn’s sample will not be available until 3-months after birth. These results will only be reported to you upon request. You can ask for your newborn’s results by emailing the study team at email@example.com
If you have not used MyChart before:
If you do not want to use MyChart and/or your MyChart has not been set-up by the time we get your research test results, we will try to contact you through the contact information available in your medical chart (i.e. email address or telephone).
If your research result is positive for active COVID-19 infection (from the nasopharyngeal swab), a member from the research team will contact you through the contact information available in your medical chart (i.e. email address or telephone number). If your research result is positive, this will be recorded in your medical chart and reported to primary obstetrical care provider or family doctor and you will be instructed to follow Ottawa Public Health guidelines (e.g. self-isolate and get tested at one of the local COVID-19 testing centres).
Questions about your research test results can be directed to the lead doctor of this study: Dr. Darine El-Chaâr, 613-737-8899 ext. 78797
Please contact the study team by email: firstname.lastname@example.org